Leading manufacturers like Johnson & Johnson, BD, Baxter, Amgen, BTG, Olympus, and many others participate as application reviewers, mentors, and judges
In 2018, MedTech Innovator will hold competitions at the Medtech Strategist Innovation Summit in Dublin, Ireland; the Wilson Sonsini Medical Device Conference in San Francisco, CA; and The MedTech Conference in Philadelphia, PA
Providers like UCLA Health, Mayo Clinic, and Providence participate as application reviewers and judges and give critical feedback on topics like healthcare economics, customer requirements, integration issues, and more
Active investors like RCT Ventures, Aphelion Capital, NEA, Life Science Angels, Healthtech Capital, Band of Angels, and others participate as application reviewers, mentors, and judges
AdvaMed and AdvaMed Accel have partnered with MedTech Innovator to provide best-in-class start-ups access to a virtual accelerator and to support AdvaMed members developing innovative and transformational medical technologies. AdvaMed represents 80 percent of medtech firms in the U.S., producing nearly 90 percent of the health care technology purchased in the U.S. each year.
Experts provide critical feedback to MedTech Innovator companies from leading service providers like Wilson Sonsini Goodrich & Rosati, Ximedica, Alira Health, Grant Thornton, Shay Glenn LLP, Silicon Valley Bank, Square One Bank, Gravitas Healthcare, and more
In 2018, MedTech Innovator and its partners will give out over $500K in cash prizes, scholarships, and in-kind awards. The competition includes several rounds where companies gain increasing amounts of exposure to industry leaders including through online application reviews, in-person pitch sessions, and audience competitions at three conferences.
MedTech Innovator Pitch – Companies identified during the review process of being of strategic interest will be invited to pitch at one of 11 regional pitch events in the US, EU, Israel and Canada in March and April. They will have the opportunity to present to and receive feedback from judges including investors, providers, and senior executives from leading medtech companies such as Johnson & Johnson, BD, Baxter, BTG, Olympus, Amgen, and many others. Based on feedback, companies may be selected to advance to participate in the MedTech Innovator Accelerator and/or Showcase Program.
MedTech Innovator Showcase – 50 companies will be selected from the MedTech Innovator Pitch round to present in the MedTech Innovator Showcase at The MedTech Conference. The MedTech Innovator Showcase is an on-stage interactive program on the main exhibit floor, which highlights the most innovative companies in sector-based sessions and is moderated by leading corporate executives and investors. All 50 Showcase companies will receive a single full scholarship to attend The MedTech Conference, as well as the invitation-only CEO Networking Dinner. Additionally, MedTech Innovator Showcase companies receive a dedicated space for one-on-one meetings over the three day conference, as well as enhanced profiles in the conference partnering website and in a published booklet distributed at the conference.
MedTech Innovator Accelerator – 20 companies will receive a place in the MedTech Innovator Accelerator, a 4-month virtual program from June – September. Accelerator companies have an unparalleled opportunity to receive continual in-depth, customized mentorship from senior leaders in the medtech industry. The accelerator commences with a 3-day kick-off event in San Francisco in June that includes exclusive networking, workshops, and pitching with investors, manufacturers, providers, and customers. All 20 Accelerator companies receive complimentary registration to the WSGR Medical Device Conference where they have opportunities to showcase their company and compete to present for a $25K Value Award and a profile in the MedTech Strategist. The Accelerator program concludes with all 20 companies participating in the Accel Leadership Seminar, the MedTech Innovator Showcase, and an opportunity to compete to present in the finals at The MedTech Conference.
Paul is MedTech Innovator’s CEO. He founded and has managed MedTech Innovator as a program within RCT Ventures for the past four years. In 2016, with the financial support of RCT and other sponsors, Paul left to run MedTech Innovator as a stand-alone company. He has spent the last 11 years as Managing Director for RCT Ventures, the investment arm of Research Corporation Technologies, Inc.
Jennifer McCaney serves as MedTech Innovator’s Director. She is a Visiting Assistant Professor at the UCLA David Geffen School of Medicine. Jennifer oversees the MedTech Innovation Program at UCLA and holds a Lecturer position at the Anderson School of Management, where she teaches courses on disruptive technologies in health care and MedTech innovation.
Kathryn Zavala is Program Director for MedTech Innovator. She earned her PhD in Molecular, Cell and Developmental Biology from UCLA. Kathryn was a Technology Fellow at the UCLA Office of Intellectual Property, where she assisted with the commercialization of university technologies.
Ashley is the Vice President of Business Development and Communications for MedTech Innovator. She previously served as the vice president of Membership and Business Development at the Advanced Medical Technology Association (AdvaMed).
She is a graduate of the University of Georgia’s Grady School of Journalism and has a master’s degree in public affairs from George Washington University.
Jenell Paul-Robinson, MSN, RN is Vice President, Clinical Value and Provider Relations at MedTech Innovator. She received her master’s degree in Nursing Administration from UCLA. Jenell brings over 20 years clinical nursing, strategic sourcing, and hospital organization value analysis experience to the team. She served on several national supply chain and academic medical center value analysis professional committees.
Johnny is a Pharmacist by training. He spent 10 years working in the retail pharmacy setting with CVS and Target. Johnny is currently an Executive MBA candidate at the UCLA Anderson School of Management, where he is focusing on Entrepreneurship and Technology Leadership. His current focus area is pharmacy innovation and consumer directed healthcare. Johnny earned a PharmD. from the University of Michigan, College of Pharmacy and a B.S. in Biochemistry and Molecular Biology from Michigan State University.